• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

胃肠及肝脏疾病与心房颤动：文献综述

Gastrointestinal and liver diseases and atrial fibrillation: a review of the literature.

作者信息

Long Michelle T, Ko Darae, Arnold Lindsay M, Trinquart Ludovic, Sherer Jason A, Keppel Sunny-Skye, Benjamin Emelia J, Helm Robert H

机构信息

Section of Gastroenterology, Boston University School of Medicine, 85 East Concord Street 7th Floor, Boston MA 02118, USA.

Evans Department of Medicine, Boston University School of Medicine, Boston, MA, USA.

出版信息

Therap Adv Gastroenterol. 2019 Apr 2;12:1756284819832237. doi: 10.1177/1756284819832237. eCollection 2019.

DOI:10.1177/1756284819832237
PMID:30984290
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6448121/
Abstract

Atrial fibrillation (AF) is the most common arrhythmia worldwide and is associated with significant morbidity and mortality. A number of risk factors have been associated with AF, though few studies have explored the association between gastrointestinal and liver diseases and AF. Additionally, AF and treatment for AF may predispose to gastrointestinal and liver diseases. We review the current literature on the bidirectional associations between gastrointestinal and liver diseases and AF. We highlight the gaps in knowledge and areas requiring future investigation.

摘要

心房颤动（AF）是全球最常见的心律失常，与显著的发病率和死亡率相关。虽然有许多风险因素与AF相关，但很少有研究探讨胃肠道和肝脏疾病与AF之间的关联。此外，AF及其治疗可能易引发胃肠道和肝脏疾病。我们综述了关于胃肠道和肝脏疾病与AF之间双向关联的当前文献。我们强调了知识空白和需要未来研究的领域。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e53d/6448121/2ce2d16b0aae/10.1177_1756284819832237-fig4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e53d/6448121/a3e8f41cd31d/10.1177_1756284819832237-fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e53d/6448121/32a2ec22bb21/10.1177_1756284819832237-fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e53d/6448121/2ce2d16b0aae/10.1177_1756284819832237-fig4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e53d/6448121/a3e8f41cd31d/10.1177_1756284819832237-fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e53d/6448121/32a2ec22bb21/10.1177_1756284819832237-fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e53d/6448121/2ce2d16b0aae/10.1177_1756284819832237-fig4.jpg

相似文献

1
Gastrointestinal and liver diseases and atrial fibrillation: a review of the literature.胃肠及肝脏疾病与心房颤动：文献综述
Therap Adv Gastroenterol. 2019 Apr 2;12:1756284819832237. doi: 10.1177/1756284819832237. eCollection 2019.
2
Mortality and morbidity in patients with atrial fibrillation and liver cirrhosis.心房颤动合并肝硬化患者的死亡率和发病率
World J Cardiol. 2020 Jul 26;12(7):342-350. doi: 10.4330/wjc.v12.i7.342.
3
Tailored Anticoagulation for Thromboembolic Risk Reduction in Paroxysmal Atrial Fibrillation.个体化抗凝治疗以降低阵发性心房颤动的血栓栓塞风险
J Innov Card Rhythm Manag. 2018 Apr 15;9(4):3116-3125. doi: 10.19102/icrm.2018.090404. eCollection 2018 Apr.
4
Atrial fibrillation in women: epidemiology, pathophysiology, presentation, and prognosis.女性心房颤动：流行病学、病理生理学、临床表现和预后。
Nat Rev Cardiol. 2016 Jun;13(6):321-32. doi: 10.1038/nrcardio.2016.45. Epub 2016 Apr 7.
5
Efficacy and safety of anticoagulation for atrial fibrillation in patients with cirrhosis: A systematic review and meta-analysis.抗凝治疗肝硬化伴心房颤动患者的疗效和安全性：系统评价和荟萃分析。
Dig Liver Dis. 2019 Apr;51(4):489-495. doi: 10.1016/j.dld.2018.12.001. Epub 2018 Dec 13.
6
The association of non-alcoholic fatty liver disease and atrial fibrillation: a review.非酒精性脂肪性肝病与心房颤动的相关性：综述。
Ann Med. 2018 Aug;50(5):371-380. doi: 10.1080/07853890.2018.1492147. Epub 2018 Jul 24.
7
Classification of atrial fibrillation as a model of decisional analysis for the treatment of patients with current atrial fibrillation observed in the emergency department.将心房颤动分类作为急诊科观察到的当前心房颤动患者治疗决策分析模型。
Eur J Emerg Med. 2000 Jun;7(2):99-109. doi: 10.1097/00063110-200006000-00003.
8
Pharmacologic management of supraventricular tachycardias in children. Part 2: Atrial flutter, atrial fibrillation, and junctional and atrial ectopic tachycardia.儿童室上性心动过速的药物治疗。第2部分：心房扑动、心房颤动以及交界性和房性异位性心动过速。
Ann Pharmacother. 1997 Nov;31(11):1347-59. doi: 10.1177/106002809703101113.
9
Atrial fibrillation: the current epidemic.心房颤动：当前的流行疾病
J Geriatr Cardiol. 2017 Mar;14(3):195-203. doi: 10.11909/j.issn.1671-5411.2017.03.011.
10
Atrial Fibrillation in Hematologic Malignancies, Especially After Autologous Hematopoietic Stem Cell Transplantation: Review of Risk Factors, Current Management, and Future Directions.血液系统恶性肿瘤中的心房颤动，尤其是自体造血干细胞移植后：危险因素、当前管理及未来方向综述
Clin Lymphoma Myeloma Leuk. 2016 Feb;16(2):70-5. doi: 10.1016/j.clml.2015.10.001. Epub 2015 Oct 24.

引用本文的文献

1
Unveiling the Multifaceted Problems Associated with Dysrhythmia.揭示心律失常相关的多方面问题。
Int J Mol Sci. 2023 Dec 23;25(1):263. doi: 10.3390/ijms25010263.
2
Anticoagulation for Atrial Fibrillation in Patients with Decompensated Liver Cirrhosis: Bold and Brave?失代偿期肝硬化患者心房颤动的抗凝治疗：大胆且勇敢？
Diagnostics (Basel). 2023 Mar 18;13(6):1160. doi: 10.3390/diagnostics13061160.
3
Anticoagulation in patients with atrial fibrillation and liver cirrhosis.心房颤动合并肝硬化患者的抗凝治疗

本文引用的文献

1
Incidence of bleeding in patients with atrial fibrillation and advanced liver fibrosis on treatment with vitamin K or non-vitamin K antagonist oral anticoagulants.维生素 K 或非维生素 K 拮抗剂口服抗凝剂治疗伴晚期肝纤维化的心房颤动患者的出血发生率。
Int J Cardiol. 2018 Aug 1;264:58-63. doi: 10.1016/j.ijcard.2018.01.097.
2
The 2018 European Heart Rhythm Association Practical Guide on the use of non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation.2018 年欧洲心脏病学会关于非维生素 K 拮抗剂口服抗凝剂在心房颤动患者中应用的实用指南。
Eur Heart J. 2018 Apr 21;39(16):1330-1393. doi: 10.1093/eurheartj/ehy136.
3
Ann Gastroenterol. 2022 Nov-Dec;35(6):557-567. doi: 10.20524/aog.2022.0745. Epub 2022 Oct 3.
4
Characterising heart rhythm abnormalities associated with Xp22.31 deletion.描述与 Xp22.31 缺失相关的心律异常。
J Med Genet. 2023 Jul;60(7):636-643. doi: 10.1136/jmg-2022-108862. Epub 2022 Nov 15.
5
Atrial fibrillation increases inpatient and 4-year all-cause mortality in critically ill patients with liver cirrhosis.心房颤动会增加肝硬化重症患者的住院率和4年全因死亡率。
Ann Transl Med. 2021 Aug;9(15):1239. doi: 10.21037/atm-21-3111.
6
Outcomes of oesophageal variceal bleeding among patients with atrial fibrillation: a propensity-matched analysis of a nationwide inpatient sample.心房颤动患者食管静脉曲张出血的结局：一项基于全国住院患者样本的倾向评分匹配分析
Arch Med Sci Atheroscler Dis. 2020 Sep 14;5:e255-e262. doi: 10.5114/amsad.2020.98949. eCollection 2020.
7
Anticoagulation in patients with advanced liver disease: an open issue.晚期肝病患者的抗凝治疗：一个未解决的问题。
Intern Emerg Med. 2021 Jan;16(1):61-71. doi: 10.1007/s11739-020-02526-6. Epub 2020 Oct 18.
8
A Review of Cardiovascular Toxicity of Microcystins.微囊藻毒素的心血管毒性研究综述。
Toxins (Basel). 2019 Aug 30;11(9):507. doi: 10.3390/toxins11090507.
Non-Vitamin K Antagonist Oral Anticoagulants and Risk of Serious Liver Injury.
非维生素 K 拮抗剂口服抗凝剂与严重肝损伤风险。
J Am Coll Cardiol. 2018 Mar 13;71(10):1105-1113. doi: 10.1016/j.jacc.2018.01.009.
4
Safety of direct oral anticoagulants vs warfarin in patients with chronic liver disease and atrial fibrillation.直接口服抗凝剂与华法林在慢性肝病合并心房颤动患者中的安全性比较。
Eur J Haematol. 2018 May;100(5):488-493. doi: 10.1111/ejh.13045. Epub 2018 Mar 13.
5
A potential relationship between gut microbes and atrial fibrillation: Trimethylamine N-oxide, a gut microbe-derived metabolite, facilitates the progression of atrial fibrillation.肠道微生物与心房颤动的潜在关系：三甲基胺 N-氧化物，一种源自肠道微生物的代谢物，促进了心房颤动的发展。
Int J Cardiol. 2018 Mar 15;255:92-98. doi: 10.1016/j.ijcard.2017.11.071.
6
Management of patients on antithrombotic agents undergoing emergency and elective endoscopy: joint Asian Pacific Association of Gastroenterology (APAGE) and Asian Pacific Society for Digestive Endoscopy (APSDE) practice guidelines.接受急诊和择期内镜检查的抗血栓治疗患者的管理：亚太胃肠病学协会（APAGE）和亚太消化内镜学会（APSDE）联合实践指南
Gut. 2018 Mar;67(3):405-417. doi: 10.1136/gutjnl-2017-315131. Epub 2018 Jan 13.
7
The effect of bariatric surgery on direct-acting oral anticoagulant drug levels.减重手术对直接口服抗凝药物水平的影响。
Thromb Res. 2018 Mar;163:190-195. doi: 10.1016/j.thromres.2017.11.006. Epub 2017 Nov 15.
8
2017 HRS/EHRA/ECAS/APHRS/SOLAECE expert consensus statement on catheter and surgical ablation of atrial fibrillation: Executive summary.2017年心房颤动导管消融与外科消融治疗专家共识声明：执行摘要（由心律学会[HRS]、欧洲心律协会[EHRA]、欧洲心血管病预防与康复协会[ECAS]、亚太心律学会[APHRS]及拉丁美洲心律学会[SOLAECE]联合发布）
J Arrhythm. 2017 Oct;33(5):369-409. doi: 10.1016/j.joa.2017.08.001. Epub 2017 Sep 15.
9
The association between non-alcoholic fatty liver disease and atrial fibrillation: A meta-analysis.非酒精性脂肪性肝病与心房颤动之间的关联：一项荟萃分析。
Clin Res Hepatol Gastroenterol. 2017 Oct;41(5):525-532. doi: 10.1016/j.clinre.2017.08.001. Epub 2017 Aug 31.
10
Beyond gut feelings: how the gut microbiota regulates blood pressure.超越直觉：肠道微生物群如何调节血压。
Nat Rev Cardiol. 2018 Jan;15(1):20-32. doi: 10.1038/nrcardio.2017.120. Epub 2017 Aug 24.